The Journal. cover art

The Journal.

The Journal.

By: The Wall Street Journal & Spotify Studios
Listen for free

About this listen

The most important stories about money, business and power. Hosted by Ryan Knutson and Jessica Mendoza. The Journal is a co-production of Spotify and The Wall Street Journal. Get show merch here: https://wsjshop.com/collections/clothingCopyright © Dow Jones & Company, Inc. All rights reserved. Politics & Government
Episodes
  • Trump's Tariffs Are Illegal. He's Got a Plan B.
    Feb 20 2026
    In a 6-3 decision, the Supreme Court ruled that President Trump’s global tariffs are illegal. It is the first time the Supreme Court has definitively struck down one of Trump’s second-term policies, saying the president went too far in enacting his most sweeping tariffs without clear authorization from Congress. WSJ’s Gavin Bade unpacks the ruling and discusses Trump’s next steps. Ryan Knutson hosts. Further Listening: - Trump's Tariffs Force a New Era in Global Trade - How Tariffs Could End Italian Pasta in the U.S. - The Tariff Trade Off: Jobs vs. Higher Prices Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Show More Show Less
    20 mins
  • In A Landmark Trial, Zuckerberg Takes the Stand
    Feb 19 2026
    Yesterday, Meta CEO Mark Zuckerberg testified in a first-of-its-kind trial with one central question: Are social media platforms causing mental health disorders among young people? The plaintiff argues that platforms like Instagram are designed to keep children addicted, potentially bypassing long-standing legal shields that have protected tech companies in the past. WSJ’s Meghan Bobrowsky takes us inside the courtroom for Mark Zuckerberg’s testimony and explains why this trial could impact thousands of other cases. Ryan Knutson hosts. Further Listening: - The Battle Within Meta Over Chatbot Safety - “The Facebook Files’ from The Journal. Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Show More Show Less
    22 mins
  • The Flu Shot Drama at the FDA
    Feb 18 2026
    The Food and Drug Administration agreed to begin a review of biotech company Moderna’s application to make a new seasonal flu shot available. The decision comes after the FDA initially refused to review the company's application. It's a back and forth that reveals increased turmoil within the agency. WSJ’s Liz Essley Whyte takes us inside the FDA’s unexpected reversals and explores what’s next for the mRNA flu vaccine. Jessica Mendoza hosts. Further Listening: - The FDA Commissioner on Vaccines and Public Trust - Breakfast Battle: The Cereal Industry vs MAHA Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
    Show More Show Less
    20 mins
No reviews yet